Gene2vec: gene subsequence embedding for prediction of mammalian N6-methyladenosine sites from mRNA

By Quan Zou, Pengwei Xing, Leyi Wei, Bin Liu. RNA: A publication of the RNA Society, 2018

484 citations recorded by the source corpus.

N6-Methyladenosine (m6A) refers to methylation modification of the adenosine nucleotide acid at the nitrogen-6 position. Many conventional computational methods for identifying N6-methyladenosine sites are limited by the small amount of data available. Taking advantage of the thousands of m6A sites detected by high-throughput sequencing, it is now possible to discover the characteristics of m6A sequences using deep learning techniques. To the best of our knowledge, our work is the first attempt to use word embedding and deep neural networks for m6A prediction from mRNA sequences. Using four deep neural networks, we developed a model inferred from a larger sequence shifting window that can predict m6A accurately and robustly. Four prediction schemes were built with various RNA sequence representations and optimized convolutional neural networks. The soft voting results from the four deep networks were shown to outperform all of the state-of-the-art methods. We evaluated these predictors mentioned above on a rigorous independent test data set and proved that our proposed method outperforms the state-of-the-art predictors. The training, independent, and cross-species testing data sets are much larger than in previous studies, which could help to avoid the problem of overfitting. Furthermore, an online prediction web server implementing the four proposed predictors has been built and is available at http://server.malab.cn/Gene2vec/.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/77c8eba3928b523c2ae12b3cb2e87f9068b105d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

Citations in the corpus

Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platform (2022, methodology): “…annotations of genes and function enrichment analysis; metaOrigin [6] supports metabolome original analysis from microbiome; Gene2vec for m6A prediction [7]; iNAP for network analysis [8]; PsRobot [9] for small RNA meta ‐ analysis; DeepKla [10] for protein lysine lactylation site prediction.”
BioSeq-Analysis2.0: an updated platform for analyzing DNA, RNA and protein sequences at sequence level and residue level based on machine learning approaches (2019, methodology): “0 on the subset of the benchmark dataset (6) based on SVM (A) and RF (B).”